Richard Hollis has over three decades of experience ranging in medical devices, pharmaceuticals, biotechnology, and digital technology.
Hollis’ career is filled with extraordinary challenges, visions, and accomplishments. He has received recognition and business awards and has been featured in multiple news outlets, including CNN, CNBC, Power Lunch, CNN, Wall Street Journal, Washington Post, Pharmaceutical Executive, Bio People, Genetic Engineering News, Business Week, 60 Minutes, and NASDAQ Opening Bell, amongst others. He has been invited to the White House and has been asked to speak several times at congressional hearings on behalf of the pharmaceutical industry’s role in emergency preparedness response to acts of terrorism from nuclear, biological, and chemical warfare.
Hollis began his career in product sales with Baxter Travenol (today Baxter International), where he specialized in launching and marketing the world’s first parenteral, enteral and intravenous solutions to the healthcare industry. Hollis later joined Imed Corporation, a world leader in drug delivery devices, in the 1980s. Imed was acquired by Warner-Lambert (today part of Pfizer Inc.). After leaving Warner-Lambert, Hollis joined Genetech and was instrumental in the launch of two blockbuster pharmaceutical products. Following the success of those product launches, Hollis joined Instromedix, a manufacturer of cardiac monitoring devices, where Hollis launched the world’s first telemedicine cardiac event monitor called the King of Hearts. Hollis then joined Bioject and launched the world’s first portable needless drug injector. Thereafter, Hollis acted on his vision of founding a new pharmaceutical company in 1992, initially self-funded and successfully brought public in 1997. The company was called Hollis-Eden Pharmaceuticals, Inc., and was the world’s first pharmaceutical company to develop a “Hormone Signaling Technology Platform” based on the Hypothalamus Adrenal Axis.
During the Great Recession of 2008 and 2009, with the collapse of the stock market, Hollis re-evaluated the state of the economy and the world at large. During Hollis’ extensive research of the Internet with his son, Hayden Hollis, a business graduate from San Diego State University, they formulated a vision of creating the world’s first fully integrated platform, predicated on the understanding and principles of holons in the digital sphere, named it Holonis, Inc.
Richard B. Hollis founded Holonis, Inc. in February of 2010 and currently serves as Founder, Chairman, and Chief Executive Officer